Evidence map›Paper›PMID 34806010›Full record

ArticleJAC-antimicrobial resistance2021

Chlorhexidine gluconate usage is associated with antiseptic tolerance in staphylococci from the neonatal intensive care unit.

Dheeraj K Sethi, Heather Felgate, Maria Diaz, Kirstin Faust, Cemsid Kiy, Paul Clarke, Christoph Härtel, Jan Rupp, Mark A Webber

Open access · goldAbstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Gut microbes · 2025
    Article
  3. Article
  4. Characterisation of neonatalMicrobial genomics · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Dheeraj K SethiQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Heather FelgateQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Maria DiazQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Kirstin FaustDepartment of Pediatrics, University of Lübeck, Lübeck, Germany.
Cemsid KiyDepartment of Pediatrics, University of Lübeck, Lübeck, Germany.
Paul ClarkeNorwich Medical School, University of East Anglia (UEA), Norwich, UK.
Christoph HärtelDepartment of Pediatrics, University of Würzburg, Würzburg, Germany.
Jan RuppDepartment of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.
Mark A WebberQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.ORCID https://orcid.org/0000-0001-9169-7592
University of East Anglia · GBUniversity of Lübeck · DENorwich Research Park · GBUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntravascular catheters are essential for care in Neonatal Intensive Care Units (NICUs) but predispose infants to catheter-associated infections including late-onset sepsis, commonly caused by CoNS. Antiseptics are applied to prevent infection with chlorhexidine (CHG) and octenidine (OCT) the most common agents used.

objectivesTo investigate the association between antiseptic use and bacterial susceptibility.

methodsCoNS isolates were collected from two NICUs with differing antiseptic regimens: Norwich, UK (using CHG) and Lubeck, Germany (using OCT). CoNS were isolated from different body sites of babies upon admission, and weekly thereafter. Antiseptic susceptibility testing was performed, and a selection underwent genome sequencing.

resultsA total of 1274 isolates were collected. UK isolates (

conclusionsLong-term CHG use may select for CHG and OCT tolerance in CoNS. This highlights the different potential for separate antiseptic regimens to select for resistance development. This could be an important factor in developing future infection control policies.

Identifiers

PMID34806010
PMCPMC8599896
OpenAlexW3213813942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.